News

  • 11 July 2016

    Zurich, SWITZERLAND – 11 July 2016 – Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems that manage fluid build-up occurring in patients with liver disease, heart disease and certain cancers, announced today the appointment of Ian Crosbie as Chief Financial Officer.

  • 1 July 2016

    Zurich, SWITZERLAND – 01 July 2016 – Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems to manage fluid build-up in patients with liver disease, congestive heart failure and certain cancers, announced today that Rolf A. Classon, former top executive of Bayer AG and Pharmacia AB, has been appointed Chairman of the Board of Directors.

  • 23 June 2016

    As endodontists, we are specialists in saving teeth, and as specialists, we are people of science. We are driven by an innate curiosity, a need to see results firsthand, and a hunger to understand exactly how things work. It’s a curiosity that naturally extends into the realm of technology. Maybe you’re a techie — the first kid on the block to have the latest gadget. Maybe you’re more conservative and likely to wait until one or more of your colleagues shares results that indicate a new technology delivers on its promises. Either way, you’re probably eager to know which new innovations can directly benefit your practice.

  • 20 June 2016

    Post-market Clinical Study Evaluates Axonics Miniaturized, Rechargeable System for Overactive Bladder Patients

  • 16 June 2016

    Wilson Therapeutics AB (publ), announces the appointment of Rick Lilley as Chief Regulatory Officer. Dr Lilley will report to CEO Jonas Hansson and will join the company’s management team.